TruthArchive.ai - Related Video Feed

Since May 2020, Remdesivir has been linked to a 30% death rate among patients receiving the drug for 5 to 10 days in hospitals. In New York, 26.9% of Medicare-aged patients who received Remdesivir died. The Cardiovascular Toxicology Journal found in October 2020 that Remdesivir is cardiotoxic and can cause death of heart cells. Despite this, the FDA and NIH continue to approve and recommend Remdesivir as the only drug for hospitalized COVID-19 patients. The World Health Organization published in April of last year that Remdesivir leads to increased acute kidney failure compared to other drugs. Shockingly, the FDA recently authorized the use of Remdesivir for newborns and children up to 18 years old.

Paxlovid is a Pfizer drug for mild to moderate COVID-19 in those at high risk for progression to severe disease, including hospitalization or death. This is a combination medication that includes a repurposed HIV drug. There is a black box warning. "Paxlovid includes ritonavir, a strong CYP3A inhibitor." "Which may lead to greater exposure of certain concomitant medications resulting in potentially severe life threatening or fatal events." The package insert lists interactions with many meds, including statins, warfarin, SSRIs, birth control pills, and ED medications; the pharmacist should review the list before giving Paxlovid. The product is used under emergency use authorization; section 13.1. Carcinogenicity studies have not been conducted: "Dose dependent increase in the incident of adenomas, a type of tumor, and, and combined carcinomas in the liver." "So the bottom line is this." If you read through the package insert, this drug has all kinds of problems, which is why I don't use it. So great caution should be used before considering Paxlovid. Alternatives include ivermectin, hydroxychloroquine, nutraceuticals.

We have a prevention protocol and an early treatment protocol. In the early treatment protocol, we use Ivermectin, which is not a horse dewormer. The claim that it's toxic is a complete lie. Over 3.7 billion doses of Ivermectin have been given to humans, making it one of the most influential drugs after penicillin. It is completely safe, even safer than Tylenol. While its efficacy can be debated, if you have limited options and a sick patient, why not try a safe and affordable drug like Ivermectin? There's nothing to lose.

There is a drug called Ivermectin that has proven to be highly effective in combating the current crisis. This is not an exaggeration, but a scientific recommendation based on extensive data gathered over the past three months. The NIH's recommendation against using Ivermectin outside of controlled trials was made in August, but since then, numerous studies from various countries have shown its miraculous impact. It has been found to completely prevent the transmission of the virus and ensure that individuals who take it do not get sick.

At home, it is recommended to treat viral replication by giving zinc and other remedies like hydroxychloroquine and ivermectin. However, the protocol followed was to provide no treatment until hospitalization. Once in the hospital, the treatment included ventilators and Remdesivir. It is claimed that Tony Fauci knew Remdesivir could be lethal, as it had caused harmful side effects in Ebola patients. The drug was then used in the pandemic, leading to kidney failure, heart failure, and organ collapse in those who died. The deaths were attributed to Remdesivir rather than the virus itself.

Ivermectin is a safe and effective drug for treating COVID-19, with studies showing it is safer than Tylenol and can help patients recover quickly, even those with low oxygen levels. A study in 2020 found a 50% reduction in hospitalizations when Ivermectin was used. Despite its proven benefits, hospital staff often resisted giving it to patients, leading to legal battles. However, when administered, even late in the illness, many patients improved and survived. The use of Ivermectin in hospitals is crucial for saving lives. Translation: Ivermectin es un medicamento seguro y efectivo para tratar el COVID-19, con estudios que muestran que es más seguro que el Tylenol y puede ayudar a los pacientes a recuperarse rápidamente, incluso aquellos con bajos niveles de oxígeno. Un estudio en 2020 encontró una reducción del 50% en hospitalizaciones cuando se usaba Ivermectin. A pesar de sus beneficios comprobados, el personal hospitalario a menudo se resistía a administrarlo a los pacientes, lo que llevaba a batallas legales. Sin embargo, cuando se administraba, incluso tarde en la enfermedad, muchos pacientes mejoraban y sobrevivían. El uso de Ivermectin en hospitales es crucial para salvar vidas.

Treat COVID-19 at home with zinc and zinc-enhancing remedies like hydroxychloroquine and ivermectin, which reduce viral spread. Current protocol delays treatment until hospitalization, using ventilators and remdesivir, known to cause harm. Fauci's promotion of remdesivir, despite its lethal side effects, led to unnecessary deaths from kidney and heart failure. The true cause of death during the pandemic was not the virus but remdesivir.

At home, it is recommended to treat viral replication by giving remedies like zinc and hydroxychloroquine, ivermectin, which reduce the spread of the disease. However, the protocol followed was different. No treatment was given until hospitalization, where ventilators and Remdesivir were used. It is known that Remdesivir can be harmful, as it caused side effects in Ebola patients. The drug was manipulated and made standard of care, leading to kidney failure, heart failure, and organ collapse in COVID-19 patients. The deaths during the pandemic were often attributed to kidney failure, which was caused by Remdesivir, not the virus itself.

Since May 2020, Remdesivir has been linked to a 30% death rate among patients receiving the drug in hospitals for 5 to 10 days. In New York, 26.9% of Medicare-aged patients who received Remdesivir died. The Cardiovascular Toxicology Journal found in October 2020 that Remdesivir causes heart cell death and is cardiotoxic. However, the FDA and NIH continue to approve and recommend Remdesivir as the only drug for hospitalized COVID-19 patients, despite the World Health Organization's report in April of last year that it causes increased acute kidney failure. Shockingly, the FDA recently authorized the use of Remdesivir for newborns and children up to 18 years old.

Since May 2020, remdesivir may result in at least 30% death in hospitalized patients who receive it for five to ten days. CMS data for Medicare patients in New York showed 26.9% of those who received remdesivir died. In October 2020, the cardiovascular toxicology journal found remdesivir causes death of heart cells, is cardiotoxic, and can lead to cardiac arrest. Despite this, in December 2020, the NIH, with Anthony Fauci, updated guidelines listing remdesivir as the only FDA-approved drug for hospitalized Americans, even though the WHO published data in April of last year that it increases acute kidney failure compared to other drugs used to treat COVID-19. As of January 21st of this year, the FDA extended emergency use authorization, making remdesivir the only authorized medication that can be administered intravenously to newborns to 18-year-olds for COVID-19.

Before the pandemic, Dr. Fauci tested Remdesivir in an Ebola trial in Africa alongside four other drugs. However, the institutional review board (IRB), responsible for ensuring safety in clinical trials, intervened and removed Remdesivir from the trial due to its high fatality rate. Ebola typically kills 53% of those infected, but Remdesivir was causing even more deaths. It seems illogical to then administer this drug to individuals with a disease that has a much lower infection fatality rate of 1%. This decision appears questionable, but unfortunately, there is a history of similar actions being taken.

I hope they use hydroxychloroquine and Z Pak with doctor's approval. It's been around for a long time, so why not try it? I want to avoid ventilators because the outcomes are not good. Hydroxychloroquine could be a game-changer if it works. It's their choice to take it, but I recommend trying it. Avoid Z Pak if you have a heart condition. Let's keep people off ventilators and find a better solution.

The speaker discusses the phenomenon of using drugs like ivermectin to treat COVID-19 without sufficient data to support its effectiveness. They emphasize the importance of safe and effective vaccines in preventing hospitalization and death from COVID-19. When patients request ivermectin, the speaker advises physicians to encourage vaccination for prevention and to provide monoclonal antibody treatment for those who qualify. For patients who are infected and at low risk for disease progression, the speaker suggests participating in clinical trials to determine the drug's efficacy. They provide the website clinicaltrials.gov for information on available trials.

Treating viral replication at home can be done with zinc and zinc-enhancing remedies like hydroxychloroquine and ivermectin. However, the protocol followed during the pandemic did not include these treatments. Instead, patients were only treated when they reached the hospital, where they were given ventilators and Remdesivir. It is known that Remdesivir can be lethal, as it caused kidney failure, heart failure, and organ collapse in many cases. The deaths during the pandemic were often attributed to kidney failure, which was actually caused by Remdesivir, not the virus itself.

Multiple studies, including one by the WHO, show that Remdesivir actually increases the risk of death. It's concerning that the federal government incentivizes hospitals to prescribe this toxic drug by offering a 20% bonus on the entire hospital bill for Medicare patients. Remdesivir costs around $3,000 per course. On the other hand, Ivermectin, as mentioned by Dr. Kory, reduces the risk of death by about 50%. Unfortunately, clinicians still use the wrong drug, Dexamethasone, in the wrong dose and for the wrong duration of time, simply because the NIH recommends it. The NIH and other agencies have disregarded multiple FDA-approved drugs that are both cost-effective and safe.

At home, it is recommended to treat viral replication by giving zinc and other zinc-enhancing remedies like hydroxychloroquine and Ivermectin. However, the protocol followed by hospitals was to provide no treatment until admission, and then use ventilators and Remdesivir, which were known to be harmful. Tony Fauci was aware of the dangers of Remdesivir, as it caused lethal side effects in Ebola patients. Despite this, he manipulated a study to make Remdesivir the standard of care, resulting in kidney failure, heart failure, and organ collapse in COVID-19 patients. The deaths attributed to the virus were actually caused by Remdesivir.

We ended our previous episode with our COVID pyramid, build layer upon layer of lies, deceit, fraud, scandals. Now, by now you’re wondering how so many hospitals, doctors, and health care workers went along with all of the above. We have reached the capstone of our nauseating COVID pyramid. Pyramid. We shall name the capstone M and M, money and murder in hospitals. Shocking as it may sound, we’ve seen it before. Remember the unjust administering the killer drug midazolam in The UK as shown in part 19? Well, The US and many other countries had their own version called remdesivir. Here’s what happened. Hospitals were given incentives, as in money, for each and every COVID casualty. According to whistleblowers, investigative journalists, lawyers, and specialists, Hospitals in The US have been receiving $13,000 for every admitted COVID patient. There have been financial extras for every COVID test, for every positive outcome. If patients were treated with the only prescribed drug, remdesivir, the hospital received yet another bonus: 20% of the entire hospital bill of the patient. Then for every patient put on a ventilator, the hospital received $39,000. And if that patient officially died of COVID nineteen, they got yet another $13,000. That’s a lot of money. According to attorney Thomas Renz and CMS whistleblowers, the hospitals receive approximately $100,000 per COVID casualty if the above protocol was followed. Now the thing is, the American hospitals received this money in advance based on the COVID predictions, based on the flawed models of people like Brooks. If the hospitals didn’t actually meet those models, they had to pay that money back at a later stage. And we’re talking millions of dollars here. So what happened? Everybody who was admitted to a hospital, for instance because of a car accident or because of cancer or diabetes or kidney failure, everybody got a PCR test to start with. Due to the ridiculous amount of cycles, there was an abundance of false positives. False positives equals positives equals COVID patients equals money. Hence, the sunrise in COVID patients. Then remdesivir left its detrimental mark just like midazolam had done in The UK. You see, remdesivir is not a new drug. It was used in 2018 during the West African Ebola outbreak. It was known to have severe adverse effects such as kidney damage, liver damage, and even death. Yet in 2020, Anthony Fauci directed that remdesivir was to be the drug hospitals used to treat COVID nineteen, hence the incentives. So what happened next? Those poor patients only got worse, after which they were put on a ventilator. After all, that was yet another bonus of many thousands of dollars pouring straight into the pockets of the hospitals. Now the problem with ventilators is that the patient is put into an induced coma. His or her breathing is taken over by a machine that puts extra pressure on the lungs called barrow pressure. In the case of damaged lungs due to for instance pneumonia, those lungs will only get worse. The chances of that patient recovering, of being able to be taken off the ventilator and to start breathing by himself are very, very small. Combined with organ failure as a result of remdesivir, the chances of that patient ever leaving the hospital alive are next to nothing.

To treat viral infections at home, zinc and its enhancers, like hydroxychloroquine and ivermectin, should be used, as they significantly reduce disease spread. However, the established protocol delayed treatment until hospitalization, where patients received ventilators and remdesivir—both potentially lethal. Remdesivir had previously shown harmful effects in Ebola trials, leading to its discontinuation due to a high rate of severe side effects. Despite this, it became standard care during the pandemic, contributing to kidney failure, heart failure, and organ collapse in patients. Many who died were reported to have kidney failure, which was not caused by the virus but rather by the effects of remdesivir.

North American science spent 15 years preparing for the next COVID after the original SARS CoV 1 outbreak in 2002-2003. By 2015-2016, research was complete. DARPA recommended to the CDC that ivermectin was the number one product to use in the event of a coronavirus pandemic. Ivermectin and hydroxychloroquine were known to be highly antiviral and immune modulatory. These effects were proven in vitro and in vivo with animals. Both medications were known to be completely safe for humans, having been used for 35 to 40 years. This knowledge was readily available for use at the next pandemic.

Treating viral infections at home can be done by providing remedies that inhibit viral replication, such as zinc and substances that enhance zinc like hydroxychloroquine and ivermectin. However, the protocol followed during the pandemic did not include these treatments. Instead, patients were only treated once they reached the hospital, where they were given ventilators and Remdesivir. It is known that Remdesivir can be lethal, as it caused kidney failure, heart failure, and organ collapse in many cases. The deaths attributed to the virus were often a result of Remdesivir rather than the virus itself.

In the discussion, Speaker 0 argues that word-of-mouth PR surrounding ivermectin “saved so many lives” and created widespread distrust in the industry, describing a shift where people questioned official stances: “My oxygen was low, and I did take ivermectin and it did work. Why are they telling me ivermectin doesn't work?” This view frames ivermectin as having proven effectiveness in practice, contrasting with public or institutional statements. Speaker 1 adds that it’s “really hard not to get angry” about the official trials, claiming that the WHO and, specifically, the Oxford trials demonstrated that ivermectin didn’t work, but that it “patently does.” They describe the fundamental problem as the way those trials were conducted, implying methodological issues. They discuss specifics of how the studies tested different drugs: Speaker 0 notes that hydroxychloroquine was given “with food” in the study, while ivermectin was given on an empty stomach, implying a potential misapplication of administration guidelines. They state that Merck’s initial labeling for ivermectin in other indications (scabies and lice) recommends administration with a fatty meal, and share a personal anecdote that their sister introduced ivermectin to the market for lice and conducted a clinical trial with many patients. Speaker 1 questions why leading clinicians would administer these drugs without knowing the correct guidelines, suggesting there should have been knowledge about administration with meals for hydroxychloroquine and with food for ivermectin. They remark, “Why the heck didn’t they know that?” Speaker 0 contends that physicians adhere to guidelines and hospital rules and fear lawsuits; they claim this fear leads to doctors “not even wanna know” certain information. They express the sentiment that the medical community was discouraged or constrained by fear of legal consequences and licensing actions, which contributed to doctors avoiding or stopping certain lines of inquiry or treatment. Overall, the dialogue centers on a perceived discrepancy between real-world outcomes of ivermectin use and official trial conclusions, the role of administration guidelines in trial results, and the influence of fear of legal ramifications on clinical practice.

Treat COVID at home with zinc, hydroxychloroquine, ivermectin, and other remedies that reduce viral spread. Current protocol delays treatment until hospitalization, using harmful ventilators and remdesivir. Fauci knew remdesivir's dangers from Ebola trials. He manipulated data to make it standard care, causing kidney and heart failure. Many pandemic deaths were due to remdesivir, not the virus.

Once it was determined to be safe, the speaker began using a treatment and found that it worked. Over 6,000 patients were treated, and those who received early treatment avoided hospitalization. Some patients came in very sick in their second week, with oxygen saturation in the low 80s, refusing to go to the hospital. The speaker's office offered them the option to possibly die there. They treated these patients with IV steroids, IV antibiotics, home oxygen, and high doses of ivermectin, without using monoclonal antibodies, and the patients were saved.

Patients were desperate for ivermectin as their loved ones died, but the focus shifted to remdesivir, a previously failed Ebola drug. By November 2020, the World Health Organization advised against its use, citing ineffectiveness and potential kidney and liver damage. The European Society of Critical Care supported this stance. Despite the warnings, the U.S. Health and Human Services incentivized hospitals with a 20% bonus for administering remdesivir, leading to widespread use. It failed to reduce mortality and caused serious injuries, with some patients dying as a result. In May 2022, the WHO reaffirmed its initial decision, stating that remdesivir should never have been used.

I've stated since May 2020 that remdesivir will result in at least 30% death in those who receive it in the hospital. I had data pulled for Medicare patients in New York, and found that 26.9% of those who received remdesivir died. As of October 2020, the cardiovascular toxicology journal found that remdesivir causes death of heart cells and can lead to cardiac arrest. Yet, in December, the NIH decided to update all guidelines for treatment drugs allowed for COVID-19, and remdesivir was the only FDA-approved drug for hospitalized Americans, despite the WHO publishing that it causes increased acute kidney failure. As of January of this year, the FDA extended an emergency use authorization, making remdesivir the only authorized medication that can be administered to newborns to 18-year-olds.